Addressing Pain Using a Mediterranean Ketogenic Nutrition Program in Older Adults with Mild Cognitive Impairment
Kamelia Klejc,Yenisel Cruz-Almeida,Julia Sheffler
DOI: https://doi.org/10.2147/jpr.s451236
IF: 2.8319
2024-05-24
Journal of Pain Research
Abstract:Kamelia Klejc, 1 Yenisel Cruz-Almeida, 2 Julia L Sheffler 1 1 Center for Translational Behavioral Science, Florida State University College of Medicine, Tallahassee, FL, USA; 2 Center for Cognitive Aging and Memory, University of Florida, Gainesville, FL, USA Correspondence: Julia L Sheffler, Email Chronic pain has negative physical and cognitive consequences in older adults and may lead to a poorer quality of life. Mediterranean ketogenic nutrition (MKN) is a promising nonpharmacological intervention for pain management, but long-term adherence is challenging due to the carbohydrate restrictive diet regimen. The main objective of this study was to evaluate the effects of the pilot MKN Adherence (MKNA) Program on pain in older adults with mild cognitive impairment and to assess whether improvements in self-reported pain were associated with adherence to MKN. Older adults (N = 58) aged 60– 85 with possible mild cognitive impairment were randomized to a 6-week MKNA arm or an MKN Education (MKNE) program arm. Both arms received the same nutrition education and group format; however, the MKNA arm received additional motivational interviewing and cognitive behavioral skills to enhance adherence. Changes in self-reported pain (Brief Pain Inventory, Roland Morris, Patient's Global Impression of Change) and adherence to MKN (ketone levels, self-reported adherence) were assessed at baseline, 6-weeks, and 3-months post intervention. Both arms showed clinically significant reductions in pain. Greater adherence to MKN across the 6-week intervention was associated with higher ratings of pain-related changes on the Patient's Global Impression of Change scale. Based on these findings, adherence to MKN may promote improvements in self-reported pain in older adults with mild cognitive impairment and findings support the need for future full-scale randomized clinical trials evaluating MKN programs on pain. Trial Registration: Clinicaltrials.gov ID: NCT04817176 Keywords: ketogenic diet, ketosis, chronic pain, adherence, nutrition program Studies suggest that over 50% of older adults report bothersome pain. 1 Chronic pain may lead to accelerated cognitive decline and increased risk of dementia. 2–4 Unfortunately, older adults may be at increased risk for adverse side-effects from pain medications, which can lead to injuries, an increased risk of hospitalization, and a poor quality of life. 5,6 Nonpharmacological interventions offer a promising alternative for pain management in older adults. 7 As the aging population in the United States is expected to more than double by 2050, chronic pain will become a more serious problem in older adults with cognitive impairment. 8 Thus, there is an imperative need to develop scalable behavioral interventions for pain designed for older adults with cognitive concerns. A recent systematic review reported an association between chronic pain and an increased risk of cognitive decline and dementia. 9 Van der Leeuw et al 2 discovered that older adults with higher levels of pain had an increased risk of developing major memory impairment. Furthermore, a 2-year longitudinal study reported an association between persistent pain and an increased risk of dementia and accelerated cognitive impairment. 3 Overall, these studies suggest that chronic pain has the risk of negative physical and cognitive consequences in older adults. One potential mechanism that may link chronic pain and Alzheimer's disease, the most common neurodegenerative disorder, is neuroinflammation. 10,11 For example, neuropathic pain in pre-clinical models activates microglia in the central nervous system, which in turn promotes neuroinflammation. 10,12 A review on the role of neuroinflammation on neurodegenerative disorders reported that pro-inflammatory responses, such as activation of cytokines, are associated with accelerated progression of neurodegenerative diseases such as Alzheimer's disease. 11 Given the link between chronic pain and cognitive decline, pain management interventions that target neuroinflammation in older adults with mild cognitive impairment may prove beneficial. Chronic pain management in older adults commonly includes pharmacological treatments, physical therapy, and other interventions. 13 Factors such as polypharmacy, changes in pharmacokinetic functions, and adverse side effects should be considered in the pharmacological management of pain in older adults. 14 Pain medications are especially problematic in older adults and may give rise to adverse reactions such cognitive impairment. 5 Thus, nonpharmacological interventions may offer a lower risk alternative to pain medications in older patients. A recent sy -Abstract Truncated-
clinical neurology